South of Gothenburg, close to AstraZeneca in Mölndal, lies a growing health innovation cluster and now, the first building has been revealed.
The focus of the new cluster is life sciences, healthcare development and digital healthcare services. The cluster, named CoValley, includes GoCo, a new urban district with innovative environments and venues that will make West Sweden an attractive destination for researchers, entrepreneurs and promising talents from all around the world, states the founders. The goal is to promote the sharing of knowledge and expertise between companies and institutions and include co-working areas, offices, accomodation for students and researchers, extra care housing, hotels, an amphitheatre, dynamic outdoor areas etc.
Construction starts 2019
The construction will begin this year. The building work will be undertaken in phases, with completion scheduled for 2028. When completed the district will offer of about 100 000 square metres of office, retail and living space, and SEK 3.5 billion will have been invested. From autumn 2021 GoCo will become both workplace and home for companies, researchers and students. The plan is for approximately 350 companies and 7000 individuals to engage in research, development and business in life sciences, healthcare development and digital health services here.
The owning company is a joint venture between Investor-owned property company Vectura Fastigheter and the Gothenburg-based property company Next Step, in close collaboration with AstraZeneca. Semrén Månsson is the architect of the new building.
The first building was showcased at the real estate fair MIPIM.
Image: Semrén Månsson
